改编新生儿阿片戒断综合征风险预测工具
模型曲线下面积0.959(95%CI 0.940-0.976),最强预测因子为母亲阿片使用障碍诊断(调整OR 47.0,95%CI 26.7-82.7),决策曲线分析显示模型在所有风险水平上优于指南筛查标准。
要点
- 严重NOWS预测模型区分度高达AUC 0.959(95%CI 0.940-0.976)。
- 母亲阿片使用障碍诊断是最强预测因子,调整OR 47.0(95%CI 26.7-82.7)。
- 决策曲线分析示模型在所有风险水平上优于指南慢性暴露筛查标准。
核心结论
- 出生时进行严重NOWS风险预测可能比单纯筛查慢性阿片暴露更能帮助临床医生调整非药物措施并决定是否延长住院。
主要发现
- 108例婴儿因NOWS接受口服吗啡治疗,1243例婴儿有慢性阿片暴露。
- 模型高度区分,受试者工作特征曲线下面积为0.959(95%CI 0.940-0.976)。
- 最强预测因子为母亲阿片使用障碍诊断,调整OR为47.0(95%CI 26.7-82.7)。
关键数值与推荐
- 严重NOWS定义为给予口服吗啡。
- 慢性阿片暴露定义为母亲在分娩前收到阿片使用障碍诊断或长效阿片类药物处方。
临床怎么用
- 临床医生可借助该预测模型在出生时识别可能发生严重NOWS的婴儿,以个体化调整非药物措施和决定是否延长住院。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The American Academy of Pediatrics recommends up to 7 days of observation for neonatal opioid withdrawal syndrome (NOWS) in infants with chronic opioid exposure. However, many of these infants will not develop NOWS, and infants with seemingly less exposure to opioids may develop severe NOWS that requires in-hospital pharmacotherapy. We adapted and validated a prediction model to help clinicians identify infants at birth who will develop severe NOWS. METHODS: This prognostic study included 33 991 births. Severe NOWS was defined as administration of oral morphine. We applied logistic regression with a least absolute shrinkage selection operator approach to develop a severe NOWS prediction model using 37 predictors. To contrast the model with guideline screening criteria, we conducted a decision curve analysis with chronic opioid exposure defined as the mother receiving a diagnosis for opioid use disorder (OUD) or a prescription for long-acting opioids before delivery. RESULTS: A total of 108 infants were treated with oral morphine for NOWS, and 1243 infants had chronic opioid exposure. The model was highly discriminative, with an area under the receiver operating curve of 0.959 (95% CI, 0.940-0.976). The strongest predictor was mothers' diagnoses of OUD (adjusted odds ratio, 47.0; 95% CI, 26.7-82.7). The decision curve analysis shows a higher benefit with the model across all levels of risk, compared with using the guideline criteria. CONCLUSION: Risk prediction for severe NOWS at birth may better support clinicians in tailoring nonpharmacologic measures and deciding whether to extend birth hospitalization than screening for chronic opioid exposure alone.
引用
- Reese TJ, Wiese AD, Leech AA, et al. Adapting a Risk Prediction Tool for Neonatal Opioid Withdrawal Syndrome. Pediatrics. 2025. PMID: 40024274. doi:10.1542/peds.2024-068673
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。